Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BURNING ROCK BIOTECH LIMITED

(BNR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Burning Rock Biotech Ltd is a holding company mainly engaged in the next generation sequencing (NGS) based cancer therapy selection. The Company operates three segments. Central Laboratory Business segment is engaged in the sales of cancer therapy selection test to individual patients. In-Hospital Business segment is engaged in the sales of reagent kits and the provision of the facilitation services for the sale of laboratory equipment to hospitals. Pharma Research and Development Services segment provide services to companies primarily in relation to the development of targeted therapies and immunotherapies for various types of cancer, and to hospitals for their studies on cancer diagnosis and treatment. Its products include OncoScreen Plus and LungPlasma. Its NGS-based cancer therapy selection tests applicable to a broad range of cancer types, including lung cancer, prostate cancer, breast cancer and others. The Company mainly conducts its businesses in the China market.

Number of employees : 938 people.
Sales per Business
20192020Delta
Central Laboratory39.9872.4%43.0869.2% +7.75%
In-hospital12.6923%17.0827.4% +34.59%
Pharma Research and Development2.574.6%2.133.4% -17.13%
USD in Million
Sales per region
20192020Delta
China55.24100%62.28100% +12.76%
USD in Million
Managers
Name Title Age Since
Yu Sheng Han Chairman & Chief Executive Officer 41 -
Leo Li Chief Financial Officer & Director 35 -
Zhi Hong Zhang, Dr. Chief Technology Officer 44 2016
Shao Kun Chuai, Dr. Chief Operating Officer & Director 40 2016
Wendy Hayes Independent Director 50 2020
Min-Jui Shen Independent Director - 2020
Sharon Liang, Dr. Vice President-Quality Assurance - 2021
Members of the board
Name Title Age Since
Yu Sheng Han Chairman & Chief Executive Officer 41 -
Shao Kun Chuai, Dr. Chief Operating Officer & Director 40 2016
Gang Lu Director 48 2014
Feng Deng Director 56 2016
Yun Xia Yang Director 46 2017
Jing Rong Director 38 2017
Leo Li Chief Financial Officer & Director 35 -
Wendy Hayes Independent Director 50 2020
Min-Jui Shen Independent Director - 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 104,548,489 75,832,769 72.5% 0 0.0% 62.2%
Stock B 1 17,324,848 0 0.0% 0 0.0%
Shareholders
NameEquities%
Baillie Gifford & Co. 8,808,988 10.1%
Matthews International Capital Management LLC 1,990,408 2.28%
OrbiMed Advisors Private Equity 1,856,201 2.13%
Canada Pension Plan Investment Board 1,238,000 1.42%
Nikko Asset Management Co., Ltd. 1,019,339 1.17%
Nikko Asset Management Americas, Inc. 919,425 1.05%
The Vanguard Group, Inc. 849,173 0.97%
Casdin Capital LLC 847,150 0.97%
Massachusetts Financial Services Co. 723,473 0.83%
New York State Common Retirement Fund 649,062 0.74%
Brand Portfolio
In partnership withAllbrands.markets
More brands of Burning Rock Biotech Limited